A Louisiana woman has filed a Taxotere and hair loss lawsuit claiming cancer drug Taxotere was the cause of her permanent hair loss.

Plaintiff Dorothy G., a resident of Louisiana, claims that as a result of taking cancer drug, Taxotere, she developed a condition known as alopecia. Alopecia is a permanent and disfiguring form of hair loss in which the hair does not return.

She is filing this Taxotere and hair loss lawsuit on several counts including failure to warn, negligence, negligent misrepresentation, fraudulent misrepresentation, fraudulent concealment and fraud and deceit.

Most people, when undergoing chemotherapy cancer treatment, expect to lose their hair. Chemotherapy targets quickly growing cells, which is why it is able to combat cancer in the manner that it does. However, chemotherapy also targets other quickly growing cells of the body including hair cells.

Taxotere and hair loss has become a very real problem for many patients who feel as if they have not been warned about the potential problems.

What is Taxotere?

Taxotere, generically known as docetaxel, has been approved for use as a chemotherapy drug since 1996. It is often used in conjunction with other chemotherapy drugs and many doctors prescribe it for the treatment of breast cancer.

It can also be used to treat other cancers including head and neck cancer, prostate cancer and lung cancer.  Taxotere is administered intravenously by a physician.

For many patients, Taxotere is a successful chemotherapy drug helping them fight cancer and extend their lives. However, for these and other patients, Taxotere and hair loss is a real concern.

Chemotherapy is known to come with its side effects including temporary hair loss. Usually, hair grows back after a patient finishes chemotherapy treatment. However, Taxotere patients often report complete lack of hair regrowth even after they have stopped treatment.

In fact, recent studies have shown that up to ten percent of Taxotere users experience permanent, disfiguring hair loss. This Taxotere and hair loss risk increases when Taxotere is used in conjunction with other drugs to treat chemotherapy.

Many patients who file Taxotere and hair loss lawsuits feel as if the company who manufactures Taxotere did not do enough to warn patients and the medical community that their drug may have lasting side effects.

While alopecia is not a severe medical disorder, it often affects the self esteem of women who are already undergoing a fight for their lives. Women who file Taxotere and hair loss lawsuits often claim that their quality of live has been reduced and they had no idea that their hair would never return.

In fact, Sanofi Aventis, who manufactures Taxotere, states that after taking Taxotere, patients’ hair generally grows back. Many patients have found that simply isn’t true.

If you or someone you love has experienced permanent and disfiguring hair loss after taking Taxotere, you may benefit from speaking to an experienced attorney. While legal compensation may not be able regrow hair, filing a Taxotere and hair loss lawsuit may help to recover lost wages and medical costs.

Dorothy’s Taxotere and Hair Loss Lawsuit is filed as part of MDL No. 2740, In Re: Taxotere (Docetaxel) Products Liability Litigation.